Skip to content

The CRyoanalgesia REgistry for Pain Management in Post carDiothoracic SUrgery Via Cryoablation of the intercostal nErves (REDUCE Registry), RP-2018-REDUCE

The CRyoanalgesia REgistry for Pain Management in Post carDiothoracic SUrgery Via Cryoablation of the intercostal nErves (REDUCE Registry), RP-2018-REDUCE - REDUCE

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00037697
Enrollment
1000
Registered
2025-08-22
Start date
2026-02-26
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-operative pain management in cardiac and thoracic procedures

Interventions

Group 1: This is a non-interventional observational study with no different arms/groups of observation. The REDUCE Registry is a retrospective and prospective, multicenter, international, , observati

Sponsors

AtriCure
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients have been scheduled by physician(s) to undergo or have undergone cryoablation of the intercostal nerves utilizing at least one AtriCure device or are similar patients treated without the use of cryoablation . EXCEPTION: Participating registry sites that wish to compare AtriCure devices, and their associated procedures’ safety and effectiveness, with other therapies for the management of intra-operative or post-operative pain, can include patients who did not receive treatment with an AtriCure device, but were treated or will be treated for similar baseline disease state. 2. Patients whose age is 18 years or above, or of legal age to give informed consent specific to state and national law.

Exclusion criteria

Exclusion criteria: 1. Patient is enrolled in a concurrent trial that may impact the treatment offered by the registry devices. 2. Patient with exclusion criteria required by local governance. 3. Women of childbearing potential who are, or plan to become, pregnant during the time of the study.

Design outcomes

Primary

MeasureTime frame
Primary analyses may include, but will not be limited to, the following: CryoNB procedural complications, incidence of death and post-procedural pain. Descriptive statistics will be used for baseline, procedure and follow-up data collected through the study. Time point of data collection according to standard of care.

Countries

Austria, Belgium, France, Germany, United Kingdom, United States

Contacts

Public ContactHauke Winter

Thoraxklinik Universitätsklinikum Heidelberg

v-thor.chirurgie@med.uni-heidelberg.de+49 6221 396-1101

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026